Sotera Health CO 10-Q quarterly reports

Sotera Health Company reported a 10% increase in net revenues for the first quarter of 2026, driven by growth across its segments, and a return to net income after a loss in the prior year period.

Sotera Health Company reported significant increases in net income and revenues for the third quarter and first nine months of 2025, while actively managing ongoing ethylene oxide tort litigation.

Sotera Health reported increased revenues and Adjusted EBITDA for Q2 2025, but net income declined due to significant Ethylene Oxide litigation settlements.

Sotera Health's first quarter 2025 shows a slight revenue increase, but net loss reported due to litigation settlement and other expenses.

Sotera Health Company's Q3 2024 results show an 8.5% increase in revenue compared to the same period last year, driven by higher volumes and favorable pricing, while also completing a significant debt refinancing.

Sotera Health Company's second quarter 2024 results show revenue growth, but net income is impacted by litigation costs and debt refinancing.

Sotera Health's first quarter of 2024 saw a 12.5% increase in revenue and a substantial rise in net income compared to the same period last year.